SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Senseonics Starts First Human Study of Freedom Glucose Monitor

Senseonics began the first human study of its Freedom glucose monitor, which has no on-body component.

SENS

Related stories